In a second study, Pastushenko et al. (2018) employed a mouse model of squamous cell carcinoma (SCC) and, by taking advantage of the different expression levels of the CD106, CD61, and CD51 cell-surface markers, identified six distinct EpCAM-negative tumor cell subpopulations, each characterized by a different degree of EMT. This evidence concerns the gene EPCAM and neoplasm.